TIL - Instil Bio - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

13.62M

Cash

154.6M

Avg Qtr Burn

-15.44M

Short % of Float

1.13%

Insider Ownership

6.84%

Institutional Own.

65.37%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ITIL-306 Details Cancer, Non-small cell lung carcinoma, Ovarian cancer, Renal cell carcinoma	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ITIL-168 Details Cancer, Melanoma	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.